Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
8
×
life sciences
national blog main
startups
8
×
boston top stories
national top stories
new york blog main
cancer
deals
new york top stories
san francisco blog main
boston
clinical trials
san diego blog main
san diego top stories
san francisco top stories
venture capital
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
fda
generic drugs
indiana blog main
indiana top stories
investing
ipo
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
takeda pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
armo biosciences
What
drugs
8
×
new
bio
medicines
roundup
aims
develop
neuro
pharmaceutical
research
therapeutics
adding
advance
ago
ahead
aiming
appetite
approach
asco
associated
backed
bails
balance
based
biology
biotech
black
brand
branded
bread
bridgebio
build
butter
buyout
called
cancer
capital
car
cash
cause
Language
unset
Current search:
startups
×
drugs
×
" boston blog main "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs